Live webcasts for the events will also be accessible on Connect’s website in the Investors section under Presentations, Events & News at investors.connectbiopharm.com. An archived replay of the ...
It is also Akeso's seventh bispecific antibody to enter clinical development. As the world's first IL-4Ra/ST2 bispecific antibody to enter the clinic, AK139 simultaneously targets and blocks both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback